BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19517779)

  • 1. [Botulinum toxin in the treatment for cerebral palsy].
    Nezu A; Otsuka Y
    No To Hattatsu; 2009 Mar; 41(2):129-31. PubMed ID: 19517779
    [No Abstract]   [Full Text] [Related]  

  • 2. Constipation as an adverse event after botulinum toxin A treatment in children with cerebral palsy.
    Vles GF; Vles JSh
    Dev Med Child Neurol; 2010 Oct; 52(10):972; author reply 974. PubMed ID: 20561010
    [No Abstract]   [Full Text] [Related]  

  • 3. Botulinum toxin type A in children and adolescents with severe cerebral palsy: a retrospective chart review.
    Mesterman R; Gorter JW; Harvey A; Lockhart J; McEwen-Hill J; Margallo K; Goldie N
    J Child Neurol; 2014 Feb; 29(2):210-3. PubMed ID: 23965398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of botulinum toxin in the treatment of cerebral palsy: comprehensive review.
    Edgar TS
    J Child Neurol; 2001 Jan; 16(1):37-46. PubMed ID: 11225955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of different dilutions of botulinum toxin type A treatment for children with cerebral palsy with spastic ankle plantarflexor: a randomized controlled trial.
    Lee JH; Sung IY; Yoo JY; Park EH; Park SR
    J Rehabil Med; 2009 Sep; 41(9):740-5. PubMed ID: 19774308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events following botulinum toxin type A treatment in children with cerebral palsy.
    Langdon K; Blair E; Davidson SA; Valentine J
    Dev Med Child Neurol; 2010 Oct; 52(10):972-3; author reply 974. PubMed ID: 20561011
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment with botulinum toxin in children with cerebral palsy: a qualitative study of parents' experiences.
    Lorin K; Forsberg A
    Child Care Health Dev; 2016 Jul; 42(4):494-503. PubMed ID: 27198886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Question 2: is there any long-term benefit from injecting botulinum toxin-A into children with cerebral palsy?
    Bradley LJ; Huntley JS
    Arch Dis Child; 2014 Apr; 99(4):392-4. PubMed ID: 24626322
    [No Abstract]   [Full Text] [Related]  

  • 9. [Botulinum toxin in the treatment of cerebral palsy--case conference].
    Nezu A; Iai M
    No To Hattatsu; 2010 May; 42(3):230-2. PubMed ID: 23858585
    [No Abstract]   [Full Text] [Related]  

  • 10. Localization of the motor endplate zone in human skeletal muscles of the lower limb: anatomical guidelines for injection with botulinum toxin.
    Van Campenhout A; Molenaers G
    Dev Med Child Neurol; 2011 Feb; 53(2):108-19. PubMed ID: 20964675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An electromyographic study on the development of optimal tactics of botulinum toxin type A injections in children with spastic forms of cerebral palsy].
    Kurenkov AL; Kuzenkova LM; Burgasova BI; Petrova SA; Klochkova OA; Nikitin SS; Artemenko AR; Mamed'iarov AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5 Pt 2):53-60. PubMed ID: 23739515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin A injection for spasticity in diplegic-type cerebral palsy.
    El O; Peker O; Kosay C; Iyilikci L; Bozan O; Berk H
    J Child Neurol; 2006 Dec; 21(12):1009-12. PubMed ID: 17156689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open-label study of botulinum toxin for upper limb spasticity in cerebral palsy.
    Wong V; Ng A; Sit P
    J Child Neurol; 2002 Feb; 17(2):138-42. PubMed ID: 11952075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
    Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
    J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of botulinum toxin injection in patients with cerebral palsy and esotropia.
    Ameri A; Mirmohammadsadeghi A; Makateb A; Bazvand F; Hosseini S
    Strabismus; 2015; 23(1):8-13. PubMed ID: 25789846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of upper limb botulinum toxin-A therapy on health-related quality of life in children with hemiplegic cerebral palsy.
    Redman TA; Finn JC; Bremner AP; Valentine J
    J Paediatr Child Health; 2008; 44(7-8):409-14. PubMed ID: 18557810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with botulinum toxin in the treatment of cerebral palsy.
    Arens LJ; Leary PM; Goldschmidt RB
    S Afr Med J; 1997 Aug; 87(8):1001-3. PubMed ID: 9323408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin injection as primary treatment for esotropia in patients with cerebral palsy.
    Malgorzata M; Wojciech K; Alina BŁ; Artur B
    Klin Oczna; 2013; 115(1):13-4. PubMed ID: 23882732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of motor end plate-targeted Botulinum toxin type A injections in children with cerebral palsyitle.
    Van Campenhout A; Bar-On L; Desloovere K; Molenaers G
    Acta Orthop Belg; 2015 Jun; 81(2):167-71. PubMed ID: 26280952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.